ERA-EDTA WORKING GROUP ON CHRONIC KIDNEY DISEASE AND MINERAL BONE DISORDER (CKD-MBD)
3th European Renal Osteodystrophy (EUROD) winter meeting
We are pleased to inform you that the 2020 EUROD winter meeting is currently in preparation to outperform all previous years for you!
The 2020 edition will take place from January 16 to January 18, 2020 at the historical Convent of Chièvres in Leuven (Belgium).
The meeting will consist of a research forum (January 16), a CME dedicated to the topic of “Vitamins and oxidative stress on the cross-roads of bone and vessels” and a hands-on CME dealing with the “Challenge of osteoporosis therapy in advanced CKD”.
Faculty (confirmed) includes M. Vervloet, S. Mazzaferro, S. Salam, A. De Vriese, M. Fusaro, L. Schurgers and P. Stenvinkel.
SUBMIT AN ABSTRACT
Submit your abstract(s) as a word file to email@example.com
Deadline: December 6 2019, 23h59
In the week of December 17 2019 authors will be notified about acceptance of their abstract as an oral presentation.
How to submit structured abstracts:
• Microsoft Word format (doc or docx)
• Maximum one A4
• Times New Roman font 12
• Margins: All sides minimally 2.5 centimeter
• Lay out: Title, Authors, Affiliations, Objective, Methods, Results, Conclusion
• Language: English
The authors of the best 5 abstracts will be awarded with an ERA-EDTA travel grant.
Travel grants can only be granted to ERA-EDTA members (cat. A and B.), who are 40 years old and younger and submitted and abstract.
Click here to read the travel grant regulations and download the application form.
For more info on
abstracts and travel grants, send an email to firstname.lastname@example.org
forregistration, venue and logistics, send an email to email@example.com
The definition of CKD-MBD is different than the previously recognized as "renal osteodystrophy", and it refers to a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following:
The term "renal osteodystrophy" is now limited to an alteration of bone morphology in patients with CKD, and it is one measure of the skeletal component of the systemic disorder of CKD-MBD that is quantifiable by histomorphometry of bone biopsy.
Thus, the CKD-MBD Working Group becomes an independent scientific organization comprising a group of European academic medical institutions aligned to CKD-MBD regarding:
|5||BOSNIA AND HERZEGOVINA|
|2||REPUBLIC OF NORTH MACEDONIA|